Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00289_DB00857_nanopub.RAGqPKi73I4q8XeS6Z-l8LO0JPzNU7ndHSSCyBiTN5HzE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00289_DB00857 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00289_DB00857 label "DDI between Atomoxetine and Terbinafine - Terbinafine, a CYP2D6 inhibitor, may reduce the metabolism and clearance of Atomoxetine. Consider alternate therapy or monitor for therapeutic/adverse effects of Atomoxetine if Terbinafine is initiated, discontinued or dose changed. [drugbank_resource:DB00289_DB00857]" assertion.
- drugbank_resource:DB00289_DB00857 identifier "drugbank_resource:DB00289_DB00857" assertion.
- drugbank_resource:DB00289_DB00857 title "DDI between Atomoxetine and Terbinafine - Terbinafine, a CYP2D6 inhibitor, may reduce the metabolism and clearance of Atomoxetine. Consider alternate therapy or monitor for therapeutic/adverse effects of Atomoxetine if Terbinafine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00857 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00289_DB00857 assertion.
- drugbank:DB00289 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00289_DB00857 assertion.